Elham Moases Ghaffary Is An Emerging Pharmaceutical Sciences Researcher Whose Academic Work Brings Together Neurology, Multiple Sclerosis, Neuroimaging, And Artificial Intelligence In Medicine. Her Research Career Has Included Work On Multiple Sclerosis, Neurological Disorders, Medical Imaging, Systematic Reviews, And More Recently, Machine Learning Applications In Epilepsy. She Is Associated With The School Of Pharmacy At The University Of Missouri-Kansas City (UMKC), Where She Is Listed In The I.Ph.D. Program In Pharmaceutical Sciences.
What Makes The Elham Moases Ghaffary Research Profile Particularly Interesting Is Its Interdisciplinary Nature. Rather Than Remaining Within A Single Area Of Pharmaceutical Research, Her Published Work Has Explored Questions About Brain Imaging, Disability, Mental Health In People With Multiple Sclerosis, Treatment-Related Complications, And The Potential Use Of Artificial Intelligence To Predict Neurological Outcomes. Her Recent 2026 Study On Treatment-Resistant Epilepsy Shows How Her Research Has Expanded Toward Data-Driven Medicine And Machine Learning.
Quick Bio Information
| Biography Detail | Information |
|---|---|
| Full Name | Elham Moases Ghaffary |
| Primary Academic Field | Pharmaceutical Sciences |
| Academic Institution | University Of Missouri-Kansas City |
| School | UMKC School Of Pharmacy |
| Program | I.Ph.D. In Pharmaceutical Sciences |
| Research Area | Multiple Sclerosis |
| Additional Research Area | Neurodegenerative And Neurological Disorders |
| Imaging Interest | Neuroimaging |
| Technology Interest | Artificial Intelligence In Medicine |
| Recent Research Area | Machine Learning And Epilepsy |
| 2026 Publication | Predicting Seizure-Free Outcomes In Treatment-Resistant Epilepsy |
| 2025 Publication | Choroid Plexus Volume In Multiple Sclerosis |
| 2024 Publication | Neuroimaging Markers And Disability Scales In Multiple Sclerosis |
| 2024 Research Area | Personality Traits, Depression, And Anxiety In MS |
| Earlier Research | Mesenchymal Stem Cells And Inflammatory Disease |
| Professional Organization | American Association Of Pharmaceutical Scientists |
| Earlier Research Affiliation | Isfahan Neurosciences Research Center |
| Research Focus | Neurology, Imaging, Pharmaceutical Sciences, And Data-Driven Medicine |
Academic Background And University Career
The Academic Journey Of Elham Moases Ghaffary Is Closely Connected With Pharmaceutical Sciences And Neurological Research. A University Of Missouri-Kansas City Women’s Council Listing Identifies Her With The School Of Pharmacy And The I.Ph.D. Program In Pharmaceutical Sciences. Her 2026 Epilepsy Publication Also Lists Her Affiliation As The School Of Pharmacy, Division Of Pharmacology And Pharmaceutical Sciences, At UMKC In Kansas City, Missouri.
This Academic Setting Is Important Because Pharmaceutical Sciences Extend Far Beyond The Traditional Idea Of Dispensing Medicines. The Field Can Include Pharmacology, Drug Action, Disease Mechanisms, Translational Research, Therapeutic Development, And The Study Of How Treatments Affect Patients. Ghaffary’s Research Shows How This Background Can Be Applied To Complicated Neurological Questions, Particularly Those Involving Multiple Sclerosis, Brain Imaging, And Treatment Outcomes.
Her Earlier Published Work Was Also Connected With The Isfahan Neurosciences Research Center At Isfahan University Of Medical Sciences. Several Of Her Neurology-Related Publications List That Affiliation, While More Recent Work Identifies UMKC As Her Institutional Home.
Research Interests And Scientific Direction
The Main Research Interests Associated With Elham Moases Ghaffary Include Multiple Sclerosis, Neurodegenerative Disorders, Neuroimaging, And AI In Medicine. These Areas May Appear Separate At First, But They Are Closely Connected In Modern Neurological Research. Scientists Increasingly Combine Clinical Information, Brain Imaging, Biological Measurements, And Computational Techniques To Better Understand disease progression and treatment outcomes.
Multiple Sclerosis Has Been One Of The Most Consistent Themes In Ghaffary’s Published Research. Her Work Has Considered Different Dimensions Of The Disease, Including Imaging Biomarkers, Psychological Factors, Treatment-Related Issues, And Possible Complications. Her More Recent Research Also Demonstrates An Interest In Applying Machine Learning To Neurological Outcomes, Showing A Broader Movement From Traditional Biomedical Research Toward Computational Medicine.
Elham Moases Ghaffary And Multiple Sclerosis Research
Multiple Sclerosis, Often Called MS, Is A Chronic Disease Affecting The Central Nervous System. Because Its Symptoms And Progression Can Vary Considerably Between Individuals, Researchers Need Multiple Ways To Understand The Disease. Ghaffary’s Research Contributions Fit Into This Larger Effort By Examining Both Clinical And Imaging-Related Questions.
One 2024 Study In The European Journal Of Medical Research Examined Personality Traits And Their Associations With Depression And Anxiety Among People With Multiple Sclerosis. The Research Included 234 People With MS And Used Standardized Measures Of Personality, Anxiety, And Depression. Ghaffary Was One Of The Authors And Was Affiliated With The Isfahan Neurosciences Research Center.
Her Publication Record Also Includes Work On COVID-19 Vaccines And Multiple Sclerosis, Hearing Loss Among People With MS, Cancer Incidence In Patients Treated With Fingolimod, And Treatment-Related Case Reports. These Studies Demonstrate That Her Interest In MS Is Not Limited To One Narrow Question But Extends Across Clinical, Therapeutic, And Patient-Related Issues.
Neuroimaging And Brain Research
Neuroimaging Is Another Important Part Of The Elham Moases Ghaffary Research Profile. Brain Imaging Can Give Researchers A Way To Study Structural And Functional Changes Associated With Neurological Disease. In MS Research, Magnetic Resonance Imaging, Or MRI, Is Especially Important Because It Can Help Researchers Examine Lesions, Brain Structures, Atrophy, And Other Markers Associated With Disease Activity And Disability.
Ghaffary Was A Contributor To A 2024 PLOS ONE Systematic Review And Meta-Analysis Examining The Relationship Between Neuroimaging Markers And Disability Scales In Multiple Sclerosis. The Study Reviewed Existing Evidence About MRI Parameters And Their Relationship With Disability In People With MS. Her Listed Contributions Included Validation And Writing The Original Draft As Well As Review And Editing.
Her Involvement In This Type Of Research Is Significant Because Systematic Reviews And Meta-Analyses Do Not Simply Report One Experiment. They Bring Together Results From Multiple Studies To Look For Broader Patterns. This Approach Can Help Researchers Understand Which Imaging Measures May Be Most Useful And Where Important Gaps In Knowledge Still Remain.
Choroid Plexus Research In Multiple Sclerosis
One Of The Most Interesting Recent Examples Of Ghaffary’s Neuroimaging Research Is Her 2025 Paper On Choroid Plexus Volume In Multiple Sclerosis. Published In The European Journal Of Medical Research, The Study Was A Systematic Review And Meta-Analysis Of The Choroid Plexus As A Potential Imaging Biomarker.
The Choroid Plexus Is A Structure Located Inside The Brain’s Ventricles And Has Important Roles In The Brain’s Fluid Environment And Immune Signaling. The Researchers Examined Whether Choroid Plexus Volume Was Different In People With MS And Whether It Was Associated With Disability Measures Or MRI Findings. The Study Suggested That Choroid Plexus Volume Could Have Potential As A Biomarker, Although The Authors Also Highlighted The Need For Further Investigation Before Such Findings Can Be Considered Definitive Clinical tools.
This Work Gives A Clear Example Of How Elham Moases Ghaffary’s Academic Journey Connects Pharmaceutical Sciences With Neurology And Advanced Imaging. It Also Shows Her Involvement In Research That Looks Beyond Conventional MS Markers To Investigate New Ways Of Understanding Disease Activity.
Artificial Intelligence In Medicine
Artificial Intelligence Is Increasingly Becoming Part Of Medical Research, Particularly When Large And Complex Datasets Are Involved. Ghaffary’s Profile Includes AI In Medicine As A Research Interest, And Her Recent Publications Provide A Practical Example Of How Machine Learning Can Be Applied To Neurological Questions.
AI Can Help Researchers Identify Patterns That May Be Difficult To Detect Through Traditional Analysis Alone. In Neurology, This Could Mean Studying MRI Measurements, Clinical Characteristics, Electrophysiological Information, Genetic Variables, Or Other Patient Data. The Goal Is Not Simply To Use Technology For Its Own Sake. Instead, The Value Comes From Determining Whether Computational Models Can Produce More Useful Predictions Or Support Better Research Decisions.
A 2025 Review Coauthored By Ghaffary Specifically Examined How Artificial Intelligence Could Transform Multiple Sclerosis Management Through Clinical, Imaging, Digital, And Molecular Applications. The Review Discussed Potential Uses Of AI In MRI Interpretation, Disease Monitoring, Relapse Prediction, Biomarker Discovery, And Personalized Treatment, While Also Emphasizing The Need For Strong Validation And Responsible Clinical Translation.
Machine Learning And Epilepsy Research
The Most Recent And Particularly Notable Publication Associated With Elham Moases Ghaffary Is Her 2026 Study, Predicting Seizure-Free Outcomes In People With Treatment-Resistant Epilepsy: A Machine Learning Approach. The Paper Was Published In Epilepsy Research In May 2026 And Lists Ghaffary As The First Author, Alongside Gerald J. Wyckoff And Omid Mirmosayyeb.
The Study Focused On A Difficult Clinical Problem. Epilepsy Surgery Can Be An Important Treatment For People Whose Seizures Do Not Respond Adequately To Medication, But Predicting Long-Term Seizure Freedom After Surgery Remains Challenging. The Researchers Investigated Whether Machine Learning Could Help With That Prediction. Their Ensemble Classification Model Achieved An Accuracy Of 77.5 Percent In The Study.
The Research Also Identified Certain Resection Locations, Including The Fusiform Gyrus, Superior Temporal Cortex, Temporal Pole, And Insula, As Particularly Predictive In The Model. Importantly, The Researchers Did Not Present Machine Learning As A Complete Solution. They Noted That Additional Clinical, Electrophysiological, And Genetic Variables Would Be Needed To Improve Long-Term Prediction.
Scientific Publications And Earlier Research
The Publication Record Of Elham Moases Ghaffary Shows A Gradual Development Of Interests Across Biomedical Science And Neurology. Her Earlier Work Included Research On Mesenchymal Stem Cells And Inflammatory Conditions. Her Profile Lists A 2020 Life Sciences Publication On The Immunomodulatory Benefits Of Caffeine-Treated Mesenchymal Stem Cells In An Experimental Arthritis Model. Earlier Work Also Included Research Presented On Rose Extract In A Rat Model Of Ulcerative Colitis And Caffeine-Treated Mesenchymal Stem Cells In Experimental Rheumatoid Arthritis.
Her Later Research Became More Concentrated On Neurological Disorders. Publications Listed On Her Professional Profile Include Research On Neurosarcoidosis, Fingolimod-Associated Bladder Lymphoma In A Patient With MS, COVID-19 Vaccination And MS, Hearing Loss In MS, Neuromyelitis Optica Spectrum Disorder Following COVID-19 Infection, And Cancer Incidence Among Patients With MS Receiving Fingolimod.
The 2023 Neurosarcoidosis Case Report Is One Example Of Her Earlier Neurological Publication Work. The Paper Identifies Ghaffary As A Contributor From The Isfahan Neurosciences Research Center And Credits Her With Methodology, Validation, And Writing Review And Editing.
Professional And Academic Activities
A Research Career Is Not Built Only Through Journal Articles. Academic Participation, Collaboration, Scientific Organizations, And Research Communication Also Matter. Available professional information connects Ghaffary With The American Association Of Pharmaceutical Scientists, Or AAPS, And Shows Her Involvement In Academic Activities At UMKC. Her Professional Profile Has Also Listed Roles Within The University’s AAPS Chapter.
These Activities Help Place Her Research In A Wider Professional Context. Pharmaceutical Sciences Is A Collaborative Field, And Researchers Often Work Across Departments And Institutions. Ghaffary’s Publications Reflect This Collaborative Approach, With Coauthors From Neurology, Neuroscience, Pharmacy, And Related Research Fields.
Scientific Skills And Research Experience
Ghaffary’s Earlier Biomedical Research Also Helps Explain The Breadth Of Her Scientific Background. Her professional information lists training or experience involving laboratory and biomedical techniques, including cell culture, flow cytometry, CRISPR-Cas9, monoclonal antibody production, and immunotherapy-related methods.
These Skills Are Relevant Because Modern Biomedical Research Often Requires Both Laboratory Understanding And Quantitative Analysis. Her Career Shows An Increasingly Broad Combination Of Experimental Science, Clinical Literature Review, Neuroimaging Research, And Computational Approaches. That Combination Is Particularly Relevant To Modern Research Into Complex Neurological Diseases.
Elham Moases Ghaffary’s Academic Journey
When Her Work Is Viewed Chronologically, A Clear Research Development Emerges. Her Earlier Publications Were Rooted In Experimental Biomedical Research, Including Inflammation And Stem Cell-Based Approaches. Her Later Work Became Increasingly Focused On Neurology And Multiple Sclerosis, With Research Questions Covering Treatment, Complications, Mental Health, Imaging, And Biomarkers.
By 2024 And 2025, Her Publication Record Included Increasingly Specialized Work On Neuroimaging Markers, MRI-Based Biomarkers, And Choroid Plexus Volume In MS. By 2025, She Had Also Coauthored A Broad Review On Artificial Intelligence And MS Management. Her 2026 Epilepsy Study Then Demonstrated A More Direct Machine Learning Application To Clinical Outcome Prediction.
This Progression Makes Her Academic Career Particularly Interesting. It Shows How A Researcher Can Move From Fundamental Biomedical Questions Toward Highly Interdisciplinary Work That Combines Disease Biology, Clinical Research, Imaging, And Computational Methods.
What Makes Her Research Notable?
The Most Distinctive Feature Of Elham Moases Ghaffary’s Research Is Its Interdisciplinary Character. Multiple Sclerosis Alone Is A Complicated Disease, And Understanding It Can Require Knowledge Of Immunology, Neurology, Pharmacology, Imaging, Psychology, And Statistics. Her published work touches several of these areas.
Her AI Research Adds Another Layer. The 2025 AI Review Examined How Computational Methods Could Support MS Diagnosis, Monitoring, And Personalized Care, While Her 2026 Epilepsy Study Applied Machine Learning To A Specific Outcome-Prediction Problem.
At The Same Time, Her Neuroimaging Publications Show An Interest In Finding Better Ways To Connect What Researchers See In Brain Scans With Disability And Disease Activity. Taken Together, These Areas Suggest A Research Approach Focused On Using Multiple Sources Of Evidence To Understand Neurological Disease More Precisely.
Future Research Directions
It Is Too Early To Make Specific Predictions About The Future Career Of Elham Moases Ghaffary, But Her Published Work Points Toward Several Important Research Areas. Artificial Intelligence, Medical Imaging, Biomarkers, Multiple Sclerosis, And Neurological Outcome Prediction Are All Active Areas Of Modern Biomedical Science.
Her Recent Research Also Shows Why Responsible Validation Matters. Machine Learning Models Can Produce Promising Results, But Accuracy In One Research Dataset Does Not Automatically Mean A Model Is Ready For Routine clinical use. The 2026 Epilepsy Study Itself Recognized The Importance Of Additional Clinical, Electrophysiological, And Genetic Information.
That Cautious Approach Is Important For Understanding Her Work. The Value Of Her Research Is Not Simply That It Uses New Technology. It Comes From Asking Whether New Methods Can Produce Reliable, Meaningful Information That Ultimately Improves Scientific Understanding Of Neurological Disease.
Final Thoughts
The Academic Story Of Elham Moases Ghaffary Is Best Understood Through Her Research Rather Than Through Unsupported Personal Details. Her Published Work Shows A Developing Career That Has Moved From Experimental Biomedical Research Toward A Stronger Focus On Neurological Disorders, Multiple Sclerosis, Neuroimaging, And Computational Medicine.
Her Work On MRI Markers And Choroid Plexus Volume Shows An Interest In Finding Better Imaging-Based Ways To Understand MS. Her Research On Personality And Mental Health Highlights The Importance Of Looking Beyond Physical Symptoms. Her 2025 Review Of AI In MS Shows An Interest In The Future Of Data-Driven Medicine, While Her 2026 Epilepsy Study Demonstrates A Practical Application Of Machine Learning To Neurological Outcome Prediction.
As Of 2026, Elham Moases Ghaffary’s Academic Journey Represents An Interesting Example Of How Pharmaceutical Sciences Can Intersect With Neuroscience, Medical Imaging, And Artificial Intelligence. Her Research Record Continues To Develop, But The Central Theme Is Already Clear: Using Modern Scientific Methods To Better Understand Complex Neurological Conditions And The Factors That Influence Patient Outcomes.
FAQs About Elham Moases Ghaffary
Who Is Elham Moases Ghaffary?
Elham Moases Ghaffary Is A Pharmaceutical Sciences Researcher Associated With The University Of Missouri-Kansas City School Of Pharmacy. Her Published Work Has Focused Heavily On Multiple Sclerosis And Neurological Research, With Additional Interests In Neuroimaging And Artificial Intelligence In Medicine.
Where Does Elham Moases Ghaffary Study?
She Is Listed With The School Of Pharmacy At The University Of Missouri-Kansas City In The I.Ph.D. Program In Pharmaceutical Sciences. Her 2026 Research Publication Also Gives Her Affiliation As UMKC’s Division Of Pharmacology And Pharmaceutical Sciences.
What Does Elham Moases Ghaffary Research?
Her Research Interests Include Multiple Sclerosis, Neurodegenerative And Neurological Disorders, Neuroimaging, And AI In Medicine. Her Publications Have Examined MS-Related Clinical Questions, MRI And Imaging Biomarkers, Mental Health Factors, And Machine Learning-Based Prediction In Epilepsy.
Has Elham Moases Ghaffary Published Research On Multiple Sclerosis?
Yes. Multiple Publications Involving Ghaffary Have Examined Different Aspects Of Multiple Sclerosis, Including Neuroimaging, Disability, Personality Traits, Depression And Anxiety, Treatment-Related Complications, Vaccination, Hearing Loss, And Cancer Risk.
What Is Her Work In Neuroimaging About?
Her Neuroimaging Research Includes Work Examining The Relationship Between MRI-Based Markers And Disability In MS. She Also Coauthored A 2025 Systematic Review And Meta-Analysis Examining Choroid Plexus Volume As A Potential Imaging Biomarker In Multiple Sclerosis.
Has She Worked With Artificial Intelligence In Medicine?
Yes. Ghaffary Coauthored A 2025 Review On Artificial Intelligence Applications In Multiple Sclerosis, Covering Clinical, Imaging, Digital, And Molecular Applications. She Also First-Authored A 2026 Machine Learning Study On Predicting Seizure-Free Outcomes Following Surgery For Treatment-Resistant Epilepsy.
What Was Her 2026 Epilepsy Study About?
The 2026 Study Investigated Whether Machine Learning Could Help Predict Long-Term Seizure Freedom In People With Treatment-Resistant Epilepsy Undergoing Surgery. The Ensemble Model Reported 77.5 Percent Accuracy, While The Authors Emphasized That Additional Clinical, Electrophysiological, And Genetic Variables Could Improve Prediction.
Why Is Elham Moases Ghaffary’s Research Interesting?
Her Research Is Interesting Because It Connects Several Modern Areas Of Biomedical Science. Her Work Brings Together Pharmaceutical Sciences, Multiple Sclerosis Research, Neuroimaging, Biomarkers, Neurological Outcomes, And Artificial Intelligence. This Interdisciplinary Approach Reflects The Increasingly Data-Driven Nature Of Contemporary Medical Research.
Learn more and explore exciting content on: Alice Pavlowsky: Biography, Research, Career, and Academic Work
Leave a Reply